Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines)

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 13, 2003, Pages 1671-1674

  Burdge, David R ^a,g   Money, Deborah M ^a   Forbes, John C ^a   Walmsley, Sharon L ^b   Smaill, Fiona M ^c   Boucher, Marc ^d   Samson, Lindy M ^e   Steben, Marc ^f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^f Clinique Médicale de l'Ouest   (Canada)

^g CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DELAVIRDINE; EFAVIRENZ; HYDROXYUREA; METHADONE; ZIDOVUDINE;

BLOOD TOXICITY; COUNSELING; DELIVERY; FATTY LIVER; FETOTOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; LABOR; LACTIC ACIDOSIS; LIVER TOXICITY; NEPHROTOXICITY; NOTE; PANCREAS DISEASE; PRACTICE GUIDELINE; PREGNANCY; PUERPERIUM; VIRUS LOAD;

EID: 0038341144     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. Burdge DR, Money DM, Forbes JC, Walmsley SL, Smaill FM, Boucher M, et al. Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice. CMAJ 2003;168(13):xxx-xxx.
2. Canadian Charter of Rights and Freedoms, Part I of the Constitution Act, 1982 being Schedule B of the Canada Act 1982 (U.K.), 1982, c. 11.
3. Winnipeg Child and Family Services (Northwest Area) v. D.F.G. [1997] 3 S.C.R. 925.
4. Tremblay v. Daigle [1989] 2 S.C.R. 530
5. Brinkman K. Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors. Clin Infect Dis 2000;31:167-9.
6. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. A meta-analysis of 15 prospective cohort studies. N Engl J Med 1999;340:977-87.
7. Maguire A, Sanchez E, Fortuny C, Casabona J, and the Working Group on HIV-1 Vertical Transmission in Catalonia. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section. AIDS 1997;11:1851-7.
8. Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF, et al. Perinatal HIV-1 transmission. Interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort. JAMA 1998;280:55-60.
9. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994;343:1464-7.
10. Kind C, Rudin C, Siegrist CA, Wyler CA, Biedermann K, Lauper J, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS 1998;12:205-10.
11. European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: a randomized clinical trial. Lancet 1999;353:1035-9.
12. Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML, et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 1995;9:913-7.
13. Read J, Kpamegan E, Tuomala R, Zorrilla C, Brown G, Hammill H, et al. Mode of delivery and postpartum morbidity among HIV-infected women: the Women and Infants Transmission Study (WITS) [abstract 683]. 6th Conference on Retroviruses and Opportunistic Infections; 1999 Jan 31 to Feb 4; Chicago.
14. Watts H, Mofenson L, Whistehouse J, Read J, Stiehm R, Lambert J, et al. Complications according to mode of delivery among HIV-positive women with CD4 counts <500 [abstract 684]. 6th Conference on Retroviruses and Opportunistic Infections; 1999 Jan 31 to Feb 4; Chicago.
15. Boucher M. Mode of delivery for pregnant women infected by the human immunodeficiency virus. J Soc Obstet Gynaecol Can 2001;23:348-50.